Biotech · Private company
Emergo Therapeutics, Inc.
Track this companyFree. Adds Emergo Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- NorketotifenPhase 2 · Influenza -Like IllnessClinicalTrials.gov · fetched Nov 12, 2026
- NorketotifenPhase 2 · Allergic RhinitisClinicalTrials.gov · fetched Nov 12, 2026
- NorketotifenPhase 2 · InfluenzaClinicalTrials.gov · fetched Nov 12, 2026
- Norketotifen Oral Capsule (Cohort 1)Phase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- Norketotifen Oral Capsule (Cohort 2)Phase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- Norketotifen Oral Capsule (Cohort 3)Phase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- Norketotifen Oral Capsule (Multiple Dose Cohort)Phase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like IllnessPHASE2 · COMPLETED · started Dec 14, 2020ClinicalTrials.gov NCT04610047 · fetched Nov 12, 2026
- Norketotifen for the Treatment of Uncomplicated Influenza-like IllnessPHASE2 · COMPLETED · started Oct 21, 2019ClinicalTrials.gov NCT04043923 · fetched Nov 12, 2026
- Efficacy and Safety of Norketotifen in Adults With Allergic RhinitisPHASE2 · COMPLETED · started Apr 1, 2019ClinicalTrials.gov NCT03887026 · fetched Nov 12, 2026
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy SubjectsPHASE1 · COMPLETED · started Oct 15, 2018ClinicalTrials.gov NCT03712163 · fetched Nov 12, 2026